Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection

Current Opinion in Hematology

Volumn 5, Issue 6, 1998, Pages 419-428

  Little, Ann Margaret ^a   Marsh, Steven G E ^b   Madrigal, J Alejandro ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ARTICLE; BONE MARROW TRANSPLANTATION; DNA SEQUENCE; DONOR; HLA MATCHING; HLA TYPING; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031774648     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199811000-00012     Document Type: Article

References (77)

1. Oudshoorn M, Cornelissen JJ, Fibbe WE, de Graeff-Meeder ER, Lie JL. Schreuder GM, et al.: Problems and possible solutions in finding an unrelated bone marrow donor: Results of consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997, 20:1011-1017. The search process, and obstacles encountered, for identifying a potential bone marrow donor for 240 Dutch patients is described. Those patients with haplotypes in high linkage disequilibrium were most likely to find a matched donor for all HLA loci studied. One third of the patients underwent transplantation, the reasons the remainder did not are given.
2. Mori M, Beatty PG, Graves M, Boucher KG, Milford EL: HLA gene and haplotype frequencies in the North American population. Transplantation 1997, 64:1017-1027. HLA-A, -B, and -DR gene and phenotypes of potential donors registered with the National Marrow Donor Program have been calculated and analyzed in relation to the major ethnic groups within the United States. These data emphasize HLA differences between different racial groups, with Caucasian, Latin, and Native Americans exhibiting less genetic diversity when compared with African and Asian Americans.
3. Trowsdale J: Molecular genetics of HLA class I and class II regions. In HLA and MHC: Genes, molecules and function. Edited by Browning M, McMichael A. Oxford: BIOS Scientific Publishers Limited; 1996:23-38.
4. Nandi D, Marusina K, Monaco JJ: How do endogenous proteins become peptides and reach the endoplasmic reticulum. Curr Top Microbiol Immunol 1998, 232:15-47.
5. Zinkemagel RM, Doherty PC: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974, 248:701-702.
6. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T-cell receptor, viral peptide, and HLA-A2. Nature 1996, 384:134-141.
7. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, Clayberger C, et al.: A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 1990, 345:41-46.
8. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, et al.: Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997, 155:105-117.
9. Parham P, Adams EJ, Amett KL: The origins of HLA-A, B, C polymorphism, Immunol Rev 1995, 143:141-180.
10. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, et al.: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C Nature 1998, 391:795-799. Tetramers composed of HLA-E molecules bound to peptides derived from the signal sequence of certain HLA-A, -B, and -C molecules were clearly shown to be the ligand for recognition by the CD94/NKG2A, B and C receptors expressed on natural killer and some T cells.
11. Ober C, Aldrich CL: HLA-G polymorphisms: Neutral evolution or novel function? J Reprod Immunol 1997, 36:1-21.
12. Nordeng TW, Gorvel JP, Bakke O: Intracellular transport of molecules engaged in the presentation of exogenous antigens. Curr Top Microbiol Immunol 1998, 232:179-215.
13. Dausset J: Leuko-agglutinins IV: Leuko-agglutinins and blood transfusion. Vox Sanguinis 1954, 4:190-198.
14. Dausset J, Nenna A, Brecy H: Leuko-agglutinins V: Leuko-agglutinins in chronic idiopathic or symptomatic pancytopenia and in paroxysmal nocturnal hemoglobulinuria. Blood 1954, 9:696.
15. Terasaki PI, McClelland JD: Microdroplet assay of human serum cytotoxins. Nature 1964, 204:998-1007.
16. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF: Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979, 47:3-61.
17. Middleton D, Bodmer J, Heyes J, Marsh SGE: HLA typing reagents: Alloantisera and monoclonal antibodies. In Histocompatibility Testing: A practical approach. Edited by Dyer P, Middleton D. Oxford: IRL Press; 1993:13-50.
18. Middleton D, Williams F: A History of DNA typing for HLA. In HLA 1997. Edited by Terasaki P, Gjertson D. Los Angeles: UCLA Tissue Typing Laboratory; 1997:61-84. An excellent chapter reviewing the history and the evolution of DNA-based typing methods utilized for transplantation matching, disease, and anthropologic studies.
19. Parham P: ASHI Rose Payne Lecture. Of Payne, polymorphism, and populations. Hum Immunol 1994, 40:77-92.
20. Parham P: Typing for class I HLA polymorphism: Past, present, and future. Eur J Immunogenet 1992, 19:347-359.
21. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, et al.: Nomenclature for factors of the HLA system. Tissue Antigens 1997, 49:297-321. The most recent, but already out of date, compilation of all WHO-recognized HLA allelic and serologic specificities for HLA class I and II loci.
22. Brown M, Krausa P: Genetic diversity of HLA-A2: Evolutionary and functional significance. Immunol Today 1996, 17:165-170.
23. Ishikawa Y, Tokunaga K, Tanaka H, Nishimura M, Muraoka M, Fujii Y, et al.: HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult. Immunogenetics 1996, 43:1-5.
24. Krausa K, Browning M: Detection of HLA gene polymorphism. In HLA and MHC: Genes, molecules and function. Edited by Browning M, McMichael A. Oxford: BIOS Scientific Publishers Limited; 1996:113-137.
25. Jordan F, McWhinnie AJ, Turner S, Gavira N, Calvert AA, Cleaver SA, et al.: Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens 1995, 45:103-110.
26. Ng J, Hurley CK, Carter C, Baxter-Lowe LA, Bing D, Chopek M et al.: Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: Progress report from year 2. Tissue Antigens 1996, 47:21-26.
27. Williams F, Mawhinney H, Middleton D: Application of an HLA-B PCR-SSOP typing method to a bone marrow donor registry. Bone Marrow Transplant 1997, 49:205-208.
28. Williams F, Mallon E, Middleton D: Development of PCR-SSOP for HLA-A typing of bone marrow registry donors. Tissue Antigens 1997, 49:61-66.
29. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF: Tissue typing the HLA-A locus from genomic DNA by sequences-specific PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993, 90:2842-2845.
30. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serologic DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
31. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI: Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 pnmer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46:355-367.
32. Lee KW, Kim YS: Serologic ambiguity and allelic frequency of the HLA-B40 family in the Korean population. Tissue Antigens 1997, 49:383-388.
33. Santamaria P, Reinsmoen NL, Lindstrom AL, Boyce-Jacino MT, Barbosa JJ, Faras AJ, et al.: Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994, 83:280-287. [Published erratum appears in Blood 1994, 83(12):3834.]
34. Rufer N, Tiercy JM, Breur-Vriesendorp B, Gauchat-Feiss D, Shi X, Slavcev A, et al.: Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. Bone Marrow Transplant 1995, 16:641-646.
35. Ellexson M, Lai-Kwan P, Lau M, Muto K, Terasaki P, Cole J, Thompson C, Hildebrand W: Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304. Hum Immunol 1997, 55:66-73. Report of a new HLA-B allele, B*1304, which was typed inconsistantly by serology and routine molecular methods. Nucleotide sequence analysis suggests that this allele arose by homologous recombination between B*1302 and B*5701.
36. Marsh SGE: HLA class II region sequences, 1998. Tissue Antigens 1998, 51:467-507. Compilation of the nucleotide and amino acid sequence alignments for HLA-DRA, -DRB, -DQA, -DQB, -DPA, -DPB, -DMA, -DMB, TAP1 and TAP2. These alignments are available at: www.anthonynolan.org.uk/HIG/index.html
37. Mason P, Parham P: HLA class I region sequences, 1998. Tissue Antigens 1998; 51:417-466. Alignments of the nucleotide (exons 2 and 3) and amino acid (α1 and α2 domains) sequences for HLA-A, -B, and -C alleles. These alignments are available at: www.anthonynolan.org.uk/HIG/index.html
38. Norgaard L, Fugger L, Jakobson BK, Svejgaard A: Sequencing-based typing of HLA-A locus using mRNA and a single locus-specific PCR followed by cycle-sequencing with AmpliTaq DNA polymerase, FS. Tissue Antigens 1997, 49:455-465.
39. Scheltinga SA, Johnston-Dow LA, White CB, Gordijn-van der Zwan A-W, Bakema JE, Rozemuller EH, et al.: A generic sequencing based typing approach for the identification of HLA-A diversity. Human Immunology 1997, 57:120-128.
40. Kotsch K, Wehling J, Köhler S, Blasczyk R: Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: Sequencing-base typing of the HLA-A gene. Tissue Antigens 1997, 50:178-191,
41. Voorter CE, Rozemuller EH, de Bruyn-Geraets D, van der Zwan AW, Tilanus MG, van den Berg-Loonen EM: Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 1997, 49:471-476. Strategies for direct sequencing of HLA-DRB alleles from two laboratories are compared. Template DNA quality is highlighted as an important factor in determining quality sequence output. Extensive quality control steps are emphasized as necessary to recognize false-negative reactions.
42. Hurley CK, Steiner N, Hoyer RJ, Menchaca E, Mitton W, Simonis T, et al.: Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types. Tissue Antigens 1996, 47:179-187.
43. Prokupek B, Dunn P, Ross J, Jordan F, Holman R, Madrigal JA, Little A-M. HLA-A*2903 expresses an epitope shared with HLA-A*8001. Tissue Antigens 1998, 51:115-118.
44. Parham P: Filling in the blanks. Tissue Antigens 1997, 50:318-321. Commentary on "HLA-blanks," summarizing what is currently known about these null alleles. There are other papers within this issue of Tissue Antigens that describe the identification of null alleles.
45. Magor KE, Taylor EJ, Shen SY, Martinez-Naves E, Valiante NM, Wells RS, et al.: Natural mactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. J Immunol 1997, 158:5242-5250. The molecular defects in three HLA-A24 null alleles were found. Each differs from the common A*2402 allele by a single nucleotide: a substitution resulting in an in-frame stop codon, an insertion that alters the reading frame, and a substitution altering a splice site, which results in low expression of the A24 product. The clinical implications of HLA-null alleles for transplantation matching is discussed.
46. Rozemuller EH, Tilanus MGJ: A computerized method to predict the discriminatory properties for class Il sequencing based typing. Hum Immunol 1996, 46:27-34.
47. Knapp LA, Lehmann E, Hennes L, Eberle ME, Watkins DI: High-resolution HLA-DRB typing using denaturing gradient gel electrophoresis and direct sequencing. Tissue Antigens 1997, 50:170-177.
48. Arguello R, Avakian H, Goldman JM, Madrigal JA: A novel method for simultaneous high resolution identification of HLA-A, HLA-B, and HLA-Cw alleles. Proc Natl Acad Sci U S A 1996, 93:10961-10965.
49. Arguello R, Pay AL, McDermott A, Ross J, Dunn P, Avakian H, et al.: Complementary strand analysis: a new approach for allelic separation in complex polyallelic genetic systems. Nucleic Acids Research 1997, 25:2236-2238. Description of a method that enables the separation of two DNA allelic products from a heterozygous loci, utilizing simple hybridization and electrophoretic methods.
50. Savage DA, Tang JP, Wood NAP, Evans J, Bidwell JL, Wee JLK, et al.: A rapid HLA-DRB1*04 subtyping method using PCR and DNA heterduplex generators. Tissue Antigens 1996, 47:284-292.
51. Clay TM, Culpan D, Pursall MC, Bradley BA, Bidwell JL: HLA-DQB1 and DQA1 matching by ambient temperature PCR-SSCP. Eur J Immunogenet 1995, 22:467-478.
52. Pursall MC, Clay TM, Bidwell JL: Combined PCR-heteroduplex and PCR-SSCP analysis for matching of HLA-A, -B and -C allotypes in marrow transplantation. Eur J Immunogenet 1996, 23:41-53.
53. Arguello JR, Little A-M, Pay AL, Gallardo D, Rojas I, Marsh SGE, et al.: Mutation-detection and typing of polymorphic loci through double-strand conformation analysis. Nature Genetics 1998, 18:192-194. A methodology for the detection of mutations, based on conformational analysis. Single nucleotide substitutions were detected in fragments up to 1000 bp in length. The system utilizes an automated DNA sequencer with laser detection and specific software for the accurate definition of polymorphisms.
54. Argüello JR, Little A-M, Bohan E, Goldman JM, Marsh SGE, Madrigal JA: High resolution HLA class I typing by Reference strand mediated conformation analysis (RSCA). Tissue Antigens 1998, 52:57-66. The application of a conformation-based mutation detection method for identification of HLA polymorphism and assignment of HLA type is described. Allelic level resolution typings are obtained without heterozygous ambiguities. This method can be automated for high through-put HLA analysis.
55. Argüello JR, Little A-M, Bohan E, Gallardo D, O'Shea J, Dodi IA, et al.: A high resolution HLA class I and class II matching method for bone marrow donor selection. Bone Marrow Transplant 1998, 22:527-534. The application of reference strand mediated conformational analysis, a conformation-based mutation detection method for the identity of HLA-A, -B, -C, -DRB1, -DQA1, -DQB1, -DPA1, and -DPB1 alleles. Analysis of a group of potential donors and patients highlights the high-resolution matching data that can be achieved by simple and rapid sample manipulations.
56. Mickelson EM, Longton G, Anasetti C, Petersdorf E, Martin P, Guthrie LA, Hansen JA: Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens 1996, 47:27-36.
57. Bamardo MC, Davey NJ, Bunce M, Brookes PA, Lechler RI, Welsh KI, Batchelor JR: A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation. Transplantation 1996, 61:1420-1423.
58. O'Shea J, Madrigal JA, Davey N, Brookes P, Scott I, Firman H, et al.: Measurement of cytotoxic T lymphocyte precursor frequencies reveals cryptic HLA class I mismatches in the context of unrelated donor bone marrow transplantation. Transplantation 1997, 64:1353-1373.
59. Young NT, Roelen DL, Dallman MJ, Morris PJ, Welsh Kl: HLA-DRB1 amino acid disparity is the major stimulus of interleukin-2 production by alloreactive helper T-lymphocytes. Immunogenetics 1998, 47:310-317. Analysis of helper T lymphocyte precursor frequencies using healthy donors demonstrates associations between HLA-DR mismatches and high helper T lymphocyte precursor frequencies. The mismatches were localized in the DRB1 β sheet and α helical regions, suggesting that bound peptides influence the alloreactive response.
60. Wang XN, Proctor SJ, Dickinson AM: Frequency analysis of recipient-reactive helper and cytotoxic T lymphocyte precursors using a combined single limiting dilution assay. Transpl Immunol 1996, 4:247-251.
61. Madrigal JA, Scott I, Arguello JR, Szydlo R, Little A-M, Goldman JM. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997, 157:153-166.
62. Little A-M, Madrigal JA: Molecular matching in allogeneic bone marrow transplantation. Eur J Immunogenet 1998, in press.
63. Nagler A, Brautbar C, Slavin S, Bishara A: Bone marrow transplantation using unrelated and family related donors: The impact of HLA-C disparity. Bone Marrow Transplant 1996, 18:891-897.
64. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, et al.: Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997, 89:1818-1823. In a controlled clinical study, the association of mismatches at HLA-C loci, as determined by sequence analysis, with graft failure was demonstrated. This association was maintained when disparities not detected by serology for HLA-A and -B were considered. This study emphasizes the need to consider HLA-C matching in the selection of an unrelated bone marrow donor.
65. Grundschober C, Rufer N, Sanchez-Mazas A, Madrigal JA, Jeannet M, Roosnek E, Tiercy JM: Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic T lymphocytes. Tissue Antigens 1997, 49:612-623. Extensive analysis of HLA-C matching in groups of potential bone marrow donors and patients demonstrated considerable disparity for HLA-C (42%), and HLA-C was shown to be the target for CD8+ T cells from positive cytotoxic T lymphocyte precursor frequency assay. Analysis of linkage between HLA-A, -B and -C loci illustrates that matching for HLA-A and -B does not result in complete matching for HLA-C.
66. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, et al.: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751. Extensive analysis of the phenotype and genotype of natural killer cell clones derived from two individuals. Killing by all clones was inhibited by combinations of self-HLA. Both donors differed in the number and types of natural killer receptors such that clones obtained from one donor killed cells from the second donor demonstrating natural killer cell alloreactivity.
67. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Martin PJ, Hansen JA: Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A 1996, 93:15358-15363.
68. Petersdorf EW, Smith AG, Mickelson EM, Longton GM, Anasetti C, Choo SY, et al.: The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993, 81:1923-1932.
69. Gaschet J, Lim A, Liem L, Vivien R, Hallet M, Harousseau J, et al.: Acute grate versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J Clin Invest 1996, 98:100-107.
70. Gaschet J, Trevino MA, Cherel M, Vivien R, Garcia-Sahuquillo A, Hallet MM, et al.: HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood 1996, 87:2345-2353.
71. Potolicchio I, Brookes PA, Madrigal JA, Lechler RI, Sorrentino R: HLA-DPB1 mismatch at position 69 is associated with high helper T lymphocyte precursor frequencies in unrelated bone marrow transplant pairs. Transplantation 1996, 62:1347-1352.
72. δ1 γδ T cells with diverse T cell receptors were obtained from lymphocytes extracted from intestinal epithelial tumors. The targets for these T cells were shown to be the α1 and α2 domains of the major histocompatibility complex-encoded MICA and MICB proteins. Recognition of MIC proteins was independent of antigen processing, and no evidence for peptide binding was found.
73. Wang DG, Fan J-B, Siao C-J, Berno A, Young P, Sapolsky R, et al.: Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998, 280:1077-1082.
74. Hurley CK, Schreuder GM, Marsh SGE, Lau M, Middleton D, Noreen H: The search for HLA-matched donors: A summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. Tissue Antigens 1997, 50:401-418. The problem of matching HLA types obtained by DNA methods with HLA types obtained by serology is addressed. Tables containing a list of identified HLA alleles; their corresponding serology type; and types assigned by multicenter studies such as the International Cell Exchange are presented.
75. Charron D: Genetic diversity of HLA: Functional and medical implication. Paris, EDK; 1997. Proceedings of the 12th International Histocompatibility Workshop held in 1996. The results of many single and multicenter studies addressing the structure and function of the HLA system are presented in two volumes.
76. Yancey AK, Coppo P, Kawanishi Y: Progress in availability of donors of color: The national Marrow Donor Program. Transplant Proc 1997, 29:3760-3765.
77. Lau M, Terasaki PI, Park MS: International cell exchange, 1994. In Clinical Transplantation. Edited by Terasaki P, Cecka J. Los Angeles: UCLA Tissue Typing Laboratory; 1994:467-488.